Innovative Oncology Software INTIO specializes in developing advanced software tools for interventional oncology procedures, indicating strong potential for sales expansion into medical institutions and clinics seeking intelligent planning and image guidance solutions for cancer treatments.

FDA-Approved Technologies The company’s flagship product, the ClearStart SVM system, has FDA 510(k) clearance for lung, liver, and lymph node applications, demonstrating regulatory credibility that can facilitate market adoption and increase sales opportunities within regulatory-conscious healthcare providers.

Growth Funding & Revenue With a funding amount of $750K and revenues ranging from $1M to $10M, INTIO is poised for growth, presenting opportunities to upsell and expand into larger healthcare markets or geographically diverse regions to boost revenue streams.

Strategic Industry Positioning Operating within the interventional oncology segment, INTIO can target specialized hospitals, cancer centers, and interventional radiology practices, aligning sales efforts with high-value clinical applications for cancer treatment innovation.

Technology Stack Advantage Utilizing a robust tech stack that includes MySQL, PHP, and Linux platforms, INTIO offers scalable, integrated solutions that can be easily adopted by tech-savvy healthcare providers, opening opportunities for tailored software enhancements and strategic partnerships.